Acorda Therapeutics, Inc. Operating Lease Right-of-Use Assets
Acorda Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $3.94 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-05-14
- 2024-03-31: Operating Lease, Right-of-Use Asset $3.94M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $4.22M.
- 2023-09-30: Operating Lease, Right-of-Use Asset $4.50M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $4.76M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-03-31 | $3.94M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.22M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $4.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $4.76M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $5.03M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.29M 10-K · filed 2024-04-01 |
| 2022-09-30 | $5.54M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.79M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $5.62M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $6.75M 10-K · filed 2023-03-15 |
| 2021-09-30 | $7.86M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.95M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $10.01M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $18.48M 10-K · filed 2022-03-18 |
| 2020-09-30 | $19.80M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $21.17M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $22.45M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $23.45M 10-K · filed 2021-03-16 |
| 2019-09-30 | $24.68M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $25.88M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $26.80M 10-Q · filed 2020-05-08 |